Staging

CHANGELOG.md

@@ -1,13 +1,8 @@
-## Hotfix Release 1.0.7
-### 04.2023
-Sonstiges:
-* add index html to static folder
-* 
-## Hotfix Release 1.0.6
-### 04.2023
+## Release 1.1.0
+### 08.2024
 Bugs:
-* updated Dockerfile, removed static ssl files
-
+* included new dataset CAMA_Pharma
+* added metadata files for new dataset
 
 ## Release 1.0.9
 ### 03.2024
@@ -21,6 +16,16 @@ Bugs:
 * added new datasets CAMA_TFP_Reduce, CAMA_TFP_Enhance
 * added metadata files for all datasets
 
+## Hotfix Release 1.0.7
+### 04.2023
+Sonstiges:
+* add index html to static folder
+*
+## Hotfix Release 1.0.6
+### 04.2023
+Bugs:
+* updated Dockerfile, removed static ssl files
+
 ## Hotfix Release 1.0.5
 ### 04.2023
 Bugs:

metadata/Datensatz_CAMA_Pharma.json

@@ -0,0 +1,36 @@
+{
+	"datensatz" : {
+		    "name": "PTSD: Psychopharmacology",
+    "data_name": "CAMA_Pharma",
+    "psychArchivesHandle": "",
+    "domain": "Clinical Psychology",
+    "metaanalysis_type": "standard",
+    "moderators": [
+      {"type": "num", "value": "r_year", "label": "Publication year"},
+      {"type": "cat", "value": "t_name", "label": "Type of SSRI"},
+      {"type": "cat", "value": "t_type_control1","label": "Type of control group"},
+      {"type": "num","value": "rob_sumscore","label": "Sumscore Risk of Bias rating"},
+      {"type": "cat", "value": "Outcome_Type","label": "Outcome data given"}
+    ],
+   "effect_strength": {
+      "label": "SMD",
+      "variable_labels": [
+        {"name": "Hedges_g", "data_label_yi": "o_g", "varianz_label_vi": "o_g_var"}
+      ]
+    },
+    "analysis_levels": ["sample_ID"]
+  },
+  "dokumentation": {
+    "title": "The treatment effect in randomized control Trials (RCTs) of pharmacological treatments (Selective Serotonin Reuptake Inhibitors (SSRIs)) for patients with posttraumatic stress disorder",
+    "url": "",
+    "doi": "",
+    "dataProvider": "Sebastian Siehl",
+    "license": "CC BY 4.0",
+    "licenseUrl": "https://creativecommons.org/licenses/by-sa/4.0/",
+    "researchQuestion": "Can we identify a significantly larger reduction in PTSD symptomatology in patients diagnosed with PTSD and treated with Selective Serotonin Reuptake Inhibitors (SSRIs) in comparison to control groups treated with placebo (passive control group) or drugs from other substance groups (active control group)?",
+    "literatureSelection": "All Randomized Control Treatments (RCTs) were included investigating the effect of SSRIs vs. at least one control treatment in adults (>18 years of age) and PTSD as main diagnosis.",
+    "effectSize": "Hedge's g",
+    "hierarchicalStructure": "The reported effect sizes per study were subdivided by main intervention vs. active and/or passive control group per timepoint (baseline/pre, post)."
+  },
+  "literatureintraege": []
+}